ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DMAC DiaMedica Therapeutics Inc

2.39
-0.10 (-4.02%)
Apr 19 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 21,009
Bid Price 2.06
Ask Price 2.42
News -
Day High 2.5412

Low
1.50

52 Week Range

High
4.75

Day Low 2.37
Company Name Stock Ticker Symbol Market Type
DiaMedica Therapeutics Inc DMAC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.10 -4.02% 2.39 16:01:02
Open Price Low Price High Price Close Price Prev Close
2.47 2.37 2.5412 2.39 2.49
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
168 21,009 $ 2.44 $ 51,304 - 1.50 - 4.75
Last Trade Time Type Quantity Stock Price Currency
16:00:00 100 $ 2.39 USD

DiaMedica Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
90.71M 37.95M - 0 -13.68M -0.36 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

DiaMedica Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No DMAC Message Board. Create One! See More Posts on DMAC Message Board See More Message Board Posts

Historical DMAC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.542.6352.292.4731,919-0.15-5.91%
1 Month2.673.342.292.7153,370-0.28-10.49%
3 Months2.693.342.292.8641,215-0.30-11.15%
6 Months2.123.342.052.7146,0070.2712.74%
1 Year1.724.751.503.1179,4520.6738.95%
3 Years9.369.9371.123.45109,263-6.97-74.47%
5 Years3.3510.881.124.38101,292-0.96-28.66%

DiaMedica Therapeutics Description

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.

Your Recent History

Delayed Upgrade Clock